Cancer BiologybioRxivPreprint
Modelling drug responses and evolutionary dynamics using triple negative breast cancer patient-derived xenografts
A. Shea, Y. Eyal-Lubling, D. Guerrero-Romero…·A. Bruna
This paper uses TNBC patient-derived xenografts to model drug responses and evolutionary dynamics, revealing a novel mechanism of olaparib response and synergistic effects with salinomycin.
DOI 10.1101/2023.01.10.523259